CVS to add weight-loss options to drug plans
CVS is adding two weight-loss options to its drug plans.
GLP-1 weight loss drugs
Eli Lilly signs deal to make, sell drugs discovered by AI
The maker of popular GLP-1 drugs Zepbound and Mounjaro could soon be making and selling drugs discovered by Ai.
Ozempic maker sues Hims & Hers
Drug maker Novo Nordisk has filed a lawsuit against telehealth provider Hims and Hers over alleged copycat versions of its weight-loss and obesity medications.
FDA to remove suicide warnings for weight loss drugs
The FDA wants suicide warnings to be taken off of some popular weight-loss medications.
People on GLP-1 drugs regain weight
A new University of Oxford review of research says many patients will return to their starting weight within two years of ending the treatment.
Wegovy starter dose now available
People wanting to lose weight now have a cheaper option.
FDA approves pill version of Wegovy
People who are severely overweight will soon have a new option to help them shed unwanted pounds.
Doctor weighs in on navigating holiday meals while managing diabetes, GLP-1 medications
Avoid over-eating processed or fried foods, as well as calorie-dense items like mashed potatoes and stuffing– to keep you from getting that uncomfortable feeling after you eat that GLP-1 medicines can provide.
Eli Lily cuts price for Zepbound
A drug that helps people lose weight now has a slimmer price tag.
Top weight loss drugs cost less if you pay with cash
Two popular weight loss drugs will now cost less, that is if you pay with cash instead of going through insurance.
